Latest drug discovery Stories
Since 2000, more than $600 billion invested in developing new medicines for patients WASHINGTON, April 20, 2015 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers
Portage Pharmaceuticals Ltd.
Studies to evaluate the effects of bryostatin-1 in a Fragile X Syndrome mouse model over a thirteen week period NEWARK, N.J., Apr. 20, 2015 /PRNewswire/ -- Neurotrope, Inc.
Designation would provide study protocol assistance and market exclusivity PETACH TIKVA, Israel, April 20, 2015 /PRNewswire/ -- Can-Fite
PHILADELPHIA, April 18, 2015 /PRNewswire/ -- Aurigene and its partner Curis, Inc.
DALLAS, April 17, 2015 /PRNewswire/ -- The report "Chromatography Resins Market in Drug Discovery by Technique (Ion Exchange, Affinity (Protein A, G & L), Hydrophobic
DALLAS, April 17, 2015 /PRNewswire/ -- LifeScienceIndustryResearch.com adds Dyskinesia - Pipeline Review, H1 2015 and Dyskinesia Global Clinical Trials Review, H1, 2015
KYOTO and OSAKA, Japan, April 16, 2015 /PRNewswire/ -- Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today
LONDON, April 16, 2015 /PRNewswire/ -- SummaryGBI Research, the leading business intelligence provider, has released its latest research,'Pancreatic Adenocarcinoma Therapeutics
- Growing in low tufty patches.